About Cancer

Home » Neurology

Neurology Videos « Go Back

FDA Approves Once-Daily Mirapex ER For The Treatment Of Early Parkinson’s Disease

Posted By: Anonymous | Posted On: Feb 22,2010 18:30 pm | View: 29 Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson’s disease (PD). MIRAPEX ER is not indicated for the treatment of advanced PD. Read More: http://www.prweb.com/releases/2010/02/prweb3637924.htm

Latest Videos :

	Learn Hacking with IDLE BRAIN \| Cyb3r Command0s https://www.youtube.com/channel/UC7hbQtQ_fCFTRBIezoM0Yiw?sub_confirmation=1
	The Circuits in our Brain -- The new way to study brain signals The complexity of the brain, and in particular the visual cortex, is so overwhelming that, in the last decades, progress toward circuit-based understanding of brain design has all but come to a halt. Part of the problem is that the usual theoretical methods, including computer simulation and mathematical analysis, are not very well suited to the sp
	Neurology Cerebellar Examination by Bromley Emergency Courses A neurology cerebellar examination video which highlights techniques examined in both the MCEM & FCEM exam. View full length videos at http://www.mcemcourses.org/revisionre...
	Partners Neurology Senior Video 2010 Introduction and "I'm Not Crying" - Lyrics/Music by Flight of the Conchords
	Brain-Healing Bridges: ScienCentral News Video Neurologists are using nanotechnology to build tiny bridges that brain cells can grow on to reconnect cells damaged by a stroke or injury. http://www.sciencentral.com/video/

Neurology Cerebellar Examination by Bromley Emergency Courses

Other Health Sources

Disclaimer: Issuers of the submissions/postings are solely responsible for the content of their submissions. Doctorsoutlook.com can't be held liable for the contents of these submissions. In case any submission damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.